Ann Belien
Founder & Chief Executive Officer Rejuvenate Biomed
Seminars
Thursday 16th July 2026
Exploiting Multi-Targeted Combinations to Preserve Muscle Quality & Functional Performance During GLP-1 Induced Weight Loss
12:10 pm
- Harnessing the power of RJx-01 to target mitochondrial health, autophagy, and neuromuscular junction stability, providing a multimodal defense against the muscle strength loss often triggered by rapid weight loss
- Utilizing clinical proof-of-mechanism data that demonstrates significant improvements in muscle strength recovery and fatigue resistance in human subjects, ensuring muscle protection
- Implementing synergistic clinical development with GLP-1 agonists to decouple muscle strength loss from fat loss, ultimately delivering a superior “high-quality” weight loss profile that improves long-term patient mobility and clinical outcomes
